| PharmaNet Development Group, Inc., a drug development services company, provides clinical drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies worldwide. The company operates in two segments, Early Stage Clinical Development and Late Stage Clinical Development. The Early Stage Clinical Development segment provides bioequivalency clinical trials, bioanalytical services, and support services. It operates Phase I clinical trial facilities in Quebec City, Canada which has 164 beds; and Montreal, Canada which has 150 beds. This segment also operates five bioanalytical laboratories in Philadelphia, Pennsylvania; Princeton, New Jersey; Quebec City and Toronto, Canada; and Barcelona, Spain. The Late Stage Clinical Development segment provides Phase II through Phase IV services, including data management and biostatistics, medical and scientific affairs, regulatory affairs and submissions, clinical information technology services, and consulting services. It conducts clinical trials in oncology, neurosciences, cardiovascular, and infectious diseases. The company also offers Web-based products that support clinical development activities. PharmaNet Development Group was founded in 1984. It was formerly known as SFBC International, Inc. and changed its name to PharmaNet Development Group, Inc. in 2006. The company is headquartered in Princeton, New Jersey. |
